Aileron Therapeutics, Inc.

NasdaqCM:ALRN Stock Report

Market Cap: US$86.7m

Aileron Therapeutics Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

James Windsor

Chief executive officer

US$715.9k

Total compensation

CEO salary percentage11.9%
CEO tenure1.1yrs
CEO ownership0.03%
Management average tenureno data
Board average tenure6.2yrs

Recent management updates

Recent updates

Companies Like Aileron Therapeutics (NASDAQ:ALRN) Could Be Quite Risky

Aug 18
Companies Like Aileron Therapeutics (NASDAQ:ALRN) Could Be Quite Risky

Is Aileron Therapeutics (NASDAQ:ALRN) In A Good Position To Deliver On Growth Plans?

Dec 30
Is Aileron Therapeutics (NASDAQ:ALRN) In A Good Position To Deliver On Growth Plans?

Aileron Therapeutics: An Assessment On A Lottery Ticket

Oct 21

Aileron Therapeutics: Solving Chemotherapy's Toxicity

May 01

Aileron Therapeutics +31% on insider buying more shares

Jan 08

Aileron raises $40M via equity offering

Jan 06

Aileron Therapeutics EPS in-line

Nov 13

CEO Compensation Analysis

How has James Windsor's remuneration changed compared to Aileron Therapeutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$25m

Mar 31 2024n/an/a

-US$18m

Dec 31 2023US$716kUS$85k

-US$16m

Compensation vs Market: James's total compensation ($USD715.92K) is about average for companies of similar size in the US market ($USD655.65K).

Compensation vs Earnings: Insufficient data to compare James's compensation with company performance.

CEO

James Windsor (58 yo)

1.1yrs

Tenure

US$715,921

Compensation

Dr. James Brian Windsor, Ph.D. is Chief Executive Officer and Director of Aileron Therapeutics, Inc. from March 11, 2024 and its President. Dr. Windsor served as Chief Operating Officer and President from...

Board Members

NamePositionTenureCompensationOwnership
James Windsor
CEO, President & Directorless than a yearUS$715.92k0.033%
$ 28.5k
Josef von Rickenbach
Independent Chairman5.4yrsUS$67.97k0.10%
$ 89.1k
Alan Musso
Independent Director1.1yrsUS$15.64k0%
$ 0
Carol Prives
Member of Scientific Advisory Board6.7yrsno datano data
Brian Druker
Member of Scientific Advisory Board6.7yrsno datano data
Alan List
Member of Scientific Advisory Board6.7yrsno datano data
Reinhard Ambros
Independent Lead Director11.4yrsUS$46.25k0.0013%
$ 1.2k
William Fairey
Independent Director1.1yrsUS$9.38k0%
$ 0
Manuel Aivado
Director6.2yrsUS$630.74k0.00023%
$ 199.3
Ulrich Steidl
Member of Scientific Advisory Boardno datano datano data

6.2yrs

Average Tenure

65.5yo

Average Age

Experienced Board: ALRN's board of directors are considered experienced (6.2 years average tenure).